Original Research
Accepted on 08 Apr 2025
A Comprehensive Pan-Cancer Analysis of LRFN4: Its Potential as a Prognostic Biomarker and Therapeutic Target for Immunotherapy
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Methods
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Review
Published on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Mini Review
Published on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Apr 2025
in Cancer Immunity and Immunotherapy